Quantitative Comparison of the Antimicrobial Efficiency of Leaching versus Nonleaching Polymer Materials

Macromolecular Bioscience
Joerg BruenkeAndreas Greiner

Abstract

New antimicrobial materials will be more and more in the focus for hygienic and clinical disease control. Antimicrobial materials have to be distinguished in leaching and nonleaching materials. For many applications of antimicrobial materials on implants the use of nonleaching materials is essential. Therefore, the antimicrobial efficiency of leaching and nonleaching polymers has been investigated quantitatively in vitro in direct comparison on a highly relevant implant of central venous catheters (CVCs) using a well-established called Certika test. This test is especially designed to test antimicrobial properties of leachable and nonleachable materials. This contribution demonstrates that newly developed nonleaching antimicrobial CVCs are equivalent to conventional leaching CVC systems in their antimicrobial performance against gram-positive and gram-negative bacteria, as well as Candida species. The use of new nonleaching antimicrobial polymers as shown here for CVCs represents a different mode of action with the aim to prevent infections also with antibiotic-resistant strains and reduced side effects.

References

Jun 5, 1999·The New England Journal of Medicine·T YasukawaA Sari
Feb 26, 2000·Annals of Internal Medicine·L A Mermel
Jul 6, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·S SaintB A Lipsky
Sep 6, 2000·Nature Medicine·T BechertJ P Guggenbichler
Apr 11, 2001·Emerging Infectious Diseases·L A Mermel
Aug 23, 2001·Current Opinion in Clinical Nutrition and Metabolic Care·A Attar, B Messing
Jan 5, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L A SampathS M Modak
Jun 1, 2005·Trends in Biotechnology·Kim Lewis, Alexander M Klibanov
Dec 29, 2006·The New England Journal of Medicine·Peter PronovostChristine Goeschel
Jan 27, 2007·The Journal of Antimicrobial Chemotherapy·Matthew E FalagasIoannis Chatzinikolaou
Mar 4, 2008·American Journal of Infection Control·Prabha RamrituNicholas Graves
May 2, 2008·Current Opinion in Infectious Diseases·Ruth E Gilbert, Melissa Harden
Nov 22, 2008·The Lancet Infectious Diseases·Anna L CaseyTom S J Elliott
Mar 20, 2010·Critical Care : the Official Journal of the Critical Care Forum·Denis FrascaOlivier Mimoz
Sep 13, 2011·Annals of Intensive Care·Jean-François TimsitCarole Schwebel
Feb 1, 2012·Acta Biomaterialia·K GlinelT Jouenne
Aug 21, 2013·Biomaterials·Davide CampocciaCarla Renata Arciola

❮ Previous
Next ❯

Citations

Aug 9, 2016·Advanced Drug Delivery Reviews·George M ViolaIssam I Raad
Aug 31, 2020·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Elif BalikciEkrem Kara
Feb 7, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Diana AlvesMaria Olívia Pereira
Mar 13, 2021·Scientific Reports·Hao WangK Scott Phillips
May 1, 2021·International Journal of Molecular Sciences·Georgia C LainiotiJoannis K Kallitsis
Sep 1, 2021·ACS Biomaterials Science & Engineering·Nathan A RohnerHorst A von Recum
Nov 17, 2021·Biomacromolecules·Romy A DopTom Hasell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.